文献速递癫痫认知障碍与痴呆

改善癫痫认知与生活质量的自我管理项目的有效性:一项实用性随机多中心试验

Effectiveness of a Self-Management Program to Improve Cognition and Quality of Life in Epilepsy: A Pragmatic, Randomized, Multicenter Trial.
PubMed 文献 · Neurology · 2022-04-06

该研究在新英格兰4个癫痫中心开展实用性重复试验,将108名参与者随机分为面对面HOBSCOTCH组、虚拟HOBSCOTCH组和等待对照组,最终分析85人。面对面HOBSCOTCH组生活质量评分较对照组改善12.4分(p < 0.001),主观认知治疗效应为6.2分(p < 0.001),虚拟干预可行但未显著优于对照组。

要点

  • 面对面HOBSCOTCH组生活质量评分较对照组改善12.4分(p < 0.001)。
  • 面对面HOBSCOTCH组主观认知治疗效应为6.2分(p < 0.001)。
  • 虚拟干预可行但未显著改善结局,生活质量疗效在6个月时减退。

核心结论

  • 本研究重复验证了HOBSCOTCH项目改善癫痫患者生活质量的有效性。
  • 虚拟干预可行但未显著优于对照组。

研究设计与样本

  • 多站点实用性重复试验,在新英格兰4个癫痫中心开展,参与者来自4个州。
  • HOBSCOTCH为8次干预,针对癫痫患者的认知障碍和生活质量。
  • 参与者被区组随机分为面对面HOBSCOTCH组、虚拟HOBSCOTCH组和等待对照组。
  • 共招募108名参与者,最终分析纳入85人(基线年龄47.5 ± 11.5岁;68%女性)。

主要发现

  • 完成面对面干预的参与者生活质量评分较对照组改善12.4分(p < 0.001)。
  • 配对比较显示面对面HOBSCOTCH组主观认知的治疗效应为6.2分(p < 0.001)。
  • 在任何时间点,客观认知或医疗服务利用方面均无有意义的组间差异。
  • 生活质量的疗效在6个月时减退。
  • 虚拟干预显示可行性,但未显著改善结局;组内分析显示虚拟组和面对面组的生活质量均有改善。

关键数值与推荐

  • 面对面HOBSCOTCH组生活质量评分较对照组改善12.4分(p < 0.001)。
  • 面对面HOBSCOTCH组主观认知治疗效应为6.2分(p < 0.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 研究在COVID-19大流行之前进行。
  • 未来研究将探索旨在提高虚拟HOBSCOTCH疗效和HOBSCOTCH治疗效应可持续性的修改。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: We conducted a multisite, pragmatic replication trial at 4 New England epilepsy centers to determine the effectiveness of Home-Based Self-Management and Cognitive Training Changes Lives (HOBSCOTCH) in a real-world setting and to assess feasibility of a virtual intervention. METHODS: HOBSCOTCH is an 8-session intervention addressing cognitive impairment and quality of life (QoL) for people with epilepsy (PWE). Participants were recruited from epilepsy centers in 4 states and block-randomized into the following groups: in-person HOBSCOTCH (H-IP), virtual HOBSCOTCH (H-V), and waitlist control. Outcome measures were assessed for all groups at baseline, 3 months, and 6 months; intervention groups received long-term follow-up at 9 and 12 months. RESULTS: A total of 108 participants were recruited, of whom 85 were included in this analysis (age at baseline 47.5 ± 11.5 years; 68% female). Participants completing the in-person intervention (H-IP) had a 12.4-point improvement in QoL score compared with controls (p < 0.001). Pairwise comparisons found a 6.2-point treatment effect for subjective cognition in the H-IP group (p < 0.001). There were no meaningful group differences in objective cognition or health care utilization at any time points and the treatment effect for QoL diminished by 6 months. The virtual intervention demonstrated feasibility but did not significantly improve outcomes compared with controls. Within-group analysis found improvements in QoL for both H-V and H-IP. DISCUSSION: This study replicated the effectiveness of the HOBSCOTCH program in improving QoL for PWE. The study was conducted prior to the COVID-19 pandemic, but the distance-delivered intervention may be particularly well-suited for the current environment. Future research will explore modifications designed to improve the efficacy of H-V and the sustainability of HOBSCOTCH's treatment effect. TRIAL REGISTRATION INFORMATION: ClinicalTrials.gov (NCT02394509). CLASSIFICATION OF EVIDENCE: This study provides Class III evidence that in-person HOBSCOTCH delivery improved subjective measures of cognition in persons with epilepsy.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Streltzov NA, Schmidt SS, Schommer LM, et al. Effectiveness of a Self-Management Program to Improve Cognition and Quality of Life in Epilepsy: A Pragmatic, Randomized, Multicenter Trial. Neurology. 2022. PMID: 35387855. doi:10.1212/WNL.0000000000200346

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。